Scheriproct Suppositories 1.3 mg/ 1 mg. Yellowish-white suppositories without cosmetic defects
PDF Leaflet Revision Date: 19 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic relief of perianal discomfort and inflammation.
Dosage (summary)
Insert 1 suppository daily; up to 3 on the first day if severe.
Special Populations
- Elderly
- Infants
Pregnancy & Breastfeeding
Contraindicated in pregnancy; insufficient data for lactation.
Key Drug Interactions
- CYP3A inhibitors may increase systemic side effects
Contraindications
- Hypersensitivity
- Viral infections
- Tuberculous processes
- Known sensitivity to local anaesthetics
Common side effects
- Skin atrophy
- Allergic skin reactions
- Blurred vision
Counselling Points
- Avoid contact with eyes
- Wash hands after use
- Consult doctor if symptoms persist
Serious warnings
- Do not use continuously for more than 7 days
- Risk of adrenal suppression
Important Disclaimer
The Scheriproct Suppositories 1.3 mg/ 1 mg. Yellowish-white suppositories without cosmetic defects professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
